Note: Ingredients listed on restricted chemical lists
EC/CAS
54-64-8
Name of the chemical
Sodium o-(ethylmercurithio)benzoate
Concentration
N/A
EC/CAS
200-210-4
Name of the chemical
Thiomersal
Concentration
N/A
General Information
Revision date
2013-10-02
Product name
IBD-SCAN
1.2.1 Relevant identified uses
A quantitative ELISA for measuring concentrations of fecal lactoferrin, a marker for fecal leukocytes. An elevated level is an indicator of intestinal inflammation
Manufacturer Name
TECHLAB, Inc
Icons in SDS
Company Information
company name
TECHLAB, Inc
Section 2
SECTION 2: Hazards identification
1999/45/EEC Except for the Diluent and Wash Buffer Concentrate, all kit components have been classified as non-hazardous according to EC Directive 67/548 EC and 1999/45/EEC. Therefore, the information in this MSDS only applies to the Diluent and Wash Buffer Concentrate. Once diluted to normal use concentration, the Diluent and Wash Buffer are classified as non- hazardous
Hazard statements
Harmful by inhalation, in contact with skin and if swallowed Danger of cumulative effects. The Conjugate, Diluent and Microassay Plate contain material of animal origin: Animal proteins are potentially infectious The Positive Control contains material of animal and human origin: Animal proteins are potentially infectious The Positive Control contains lactoferrin which is a human derived material. Material has been tested and found negative for antibody to HIV-1, HIV-2, HCV, and HbsAg. No known test method can offer complete assurance that infectious agents are absent. ALL HUMAN SOURCE PRODUCTS SHOULD BE HANDLED AS POTENTIALLY INFECTIOUS MATERIAL. A procedure for handling biohazards is published in the CDC/NIH Manual of Biosafety in Microbiology & Biomedical Laboratories. The Lactoferrin Standards (5) contain material of animal and human origin: Animal proteins are potentially infectious The Lactoferrin Standards contain lactoferrin which is a human derived material. Material has been tested and found negative for antibody to HIV-1, HIV-2, HCV, and HbsAg. No known test method can offer complete assurance that infectious agents are absent. ALL HUMAN SOURCE PRODUCTS SHOULD BE HANDLED AS POTENTIALLY INFECTIOUS MATERIAL. A procedure for handling biohazards is published in the CDC/NIH Manual of Biosafety in Microbiology & Biomedical Laboratories
